drugset / Trial / NCT01870466
Pharmacodynamic Drug Interaction Between Cilostazol and Statins
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to evaluate pharmacodynamic drug interaction between cilostazol and statins (simvastatin as a CYP3A substrate and rosuvastatin as a non-CYP3A substrate) in healthy male subjects.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-09
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilostazol | Small molecule | 100 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Simvastatin | Small molecule | 40 mg | — |
Indications
No indication recorded.